(HealthDay)—Implantable cardioverter-defibrillators (ICDs) are associated with a high risk of long-term complications, according to research published online May 3 in the Annals of Internal Medicine.
May 3, 2016
0
2
Patients with moderate-to-severe chronic kidney disease who received cardiac resynchronization therapy with defibrillator had a lower risk of hospitalization for heart failure or death from this condition compared to patients ...
Dec 7, 2015
0
11
Medtronic has recalled nearly 97,000 advanced InSync III pacemakers for treating heart failure, saying the globally distributed devices may have batteries that put out less power than they should.
Dec 2, 2015
0
11
Israeli researchers have successfully established a new approach for pacing the heart and synchronizing its mechanical activity without the use of a conventional electrical pacemaker. This novel biologic strategy employs ...
Jun 23, 2015
0
130
Patients who had higher activity levels following ICD implantation had better survival, according to research in the Journal of the American Heart Association. The research will be simultaneously presented at the Heart Rhythm ...
May 15, 2015
0
5
Most patients with implantable cardioverter defibrillators (ICDs)—small devices placed in a person's chest to help treat irregular heartbeats with electrical pulses, or shocks—haven't thought about device deactivation ...
Nov 17, 2014
0
0
Racial and ethnic minorities who receive implantable devices to treat heart failure derive the same substantial survival benefit from these therapies as white patients, new UCLA-led research shows.
Aug 18, 2014
0
0
Although the term "heart failure" is a bit of a misnomer, there's no doubt about its dire consequences. There are over 5 million people in the United States whose hearts simply fail to pump sufficient blood with enough force ...
Aug 5, 2014
0
0
Cardiac resynchronization therapy plus defibrillator implantation (CRT-D) sometimes helps women with heart failure more than men, although women are less likely to receive CRT-D than men.
Jun 23, 2014
0
0
(HealthDay)—The U.S. Food and Drug Administration has approved an application from Medtronic for revised labeling for two cardiac resynchronization pacemakers (CRT-P) and eight cardiac resynchronization defibrillators (CRT-D). ...
Apr 15, 2014
0
0
